Preferred Label : Tucatinib;

NCIt synonyms : N6-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)phenyl)quinazoline-4,6-diamine; ErbB-2 Inhibitor ARRY-380; Irbinitinib;

NCIt definition : An orally bioavailable inhibitor of the human epidermal growth factor receptor tyrosine kinase ErbB-2 (also called HER2) with potential antineoplastic activity. Tucatinib selectively binds to and inhibits the phosphorylation of ErbB-2, which may prevent the activation of ErbB-2 signal transduction pathways, resulting in growth inhibition and death of ErbB-2-expressing tumor cells. ErbB-2 is overexpressed in a variety of cancers and plays an important role in cellular proliferation and differentiation.;

UNII : 234248D0HH;

InChIKey : SDEAXTCZPQIFQM-UHFFFAOYSA-N;

CAS number : 937263-43-9;

Drug name : Tukysa;

Molecule name : ARRY-380; ONT-380; ONT 380; ARRY 380;

NCI Metathesaurus CUI : CL383576;

Codes from synonyms : 4683;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-atu-rtu/tucatinib-50-mg-comprime-pellicule
2021
false
false
false
France
French
administration, oral
summary of product characteristics
package leaflet
guidelines for drug use
antineoplastic agents
protein kinase inhibitors
tucatinib
Tucatinib
Tucatinib
oxazoles
pyridines
quinazolines
antineoplastic combined chemotherapy protocols
adult
breast neoplasms
Trastuzumab
Capecitabine
Capecitabine/Trastuzumab/Tucatinib Regimen
neoplasm metastasis
receptor, erbB-2
tucatinib
tucatinib
HER2-Positive Breast Carcinoma
oxazoles
pyridines
quinazolines

---
Nous contacter.
10/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.